Targeted Revision of ICH Q1s/Q5C - Opportunities with Science and Risk-Based Approaches
Speaker Presentation Zimmerman Boris Genentech, a Member of the Roche Group 2022
Targeted Revision of ICH Q1s/Q5C - Opportunities with Science and Risk-Based Approaches